The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756.

The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756.

Publication date: Sep 01, 2025

Open Access PDF

Concepts Keywords
Disease Adverse
Kidney Covid
Nirmatrelvir Dis
Ofae756 Disease
Forum
Infect
Kidney
Long
Nirmatrelvir
Ofae756
Open
Outcomes
Ritonavir
Short
Term

Semantics

Type Source Name
drug DRUGBANK Ritonavir
disease MESH COVID-19
disease MESH Kidney Disease
disease MESH Infectious Diseases
disease MESH chronic kidney disease

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *